title: Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
authors.affiliation: Neurologische Universitätsklinik Klinikum Carl Gustav Carus, Fetscherstraße 74, 01307, Dresden, Germany, Tjalf.Ziemssen@uniklinikum-dresden.de.
authors.forename: Tjalf
authors.initials: T
authors.lastname: Ziemssen
authors.forename: Ovidiu A
authors.initials: OA
authors.lastname: Bajenaru
authors.forename: Adriana
authors.initials: A
authors.lastname: Carrá
authors.forename: Nina
authors.initials: N
authors.lastname: de Klippel
authors.forename: João
authors.initials: J
authors.lastname: Correia de Sá
authors.forename: Astrid
authors.initials: A
authors.lastname: Edland
authors.forename: Jette L
authors.initials: JL
authors.lastname: Frederiksen
authors.forename: Olivier
authors.initials: O
authors.lastname: Heinzlef
authors.forename: Klimentini E
authors.initials: KE
authors.lastname: Karageorgiou
authors.forename: Rafael H
authors.initials: RH
authors.lastname: Lander Delgado
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Landtblom
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Macías Islas
authors.forename: Niall
authors.initials: N
authors.lastname: Tubridy
authors.forename: Yossi
authors.initials: Y
authors.lastname: Gilgun-Sherki